![Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study | Semantic Scholar Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1c254b2dc5f2dd191340b4f9c8f79983521fa3a3/7-Figure2-1.png)
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study | Semantic Scholar
![Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine | Science Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine | Science](https://www.science.org/cms/asset/e4d6f0e6-4d25-4ce2-88f1-c2372ed8ecc5/368_401_f1.gif)
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine | Science
![Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study - The Lancet Infectious Diseases Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2116720218/2085076959/gr1.gif)
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study - The Lancet Infectious Diseases
![Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021 | MMWR Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/figures/mm7124a2-F1-large.gif?_=92110)
Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021 | MMWR
![Polio Vaccine – Novel Oral (nOPV) Monovalent type 2 | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control) Polio Vaccine – Novel Oral (nOPV) Monovalent type 2 | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)](https://extranet.who.int/pqweb/sites/default/files/EUL_nOPV2_50doses_PTBioFarma_container_image_2D-2022.jpg?itok=F_qXgoD4)
Polio Vaccine – Novel Oral (nOPV) Monovalent type 2 | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)
![The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks - ScienceDirect The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1931312820305746-fx1.jpg)
The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks - ScienceDirect
![Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization | npj Vaccines Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-020-0176-7/MediaObjects/41541_2020_176_Fig1_HTML.png)
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization | npj Vaccines
IMPLEMENTATION OF NOVEL ORAL POLIO VACCINE TYPE 2 (nOPV2) FOR CIRCULATING VACCINE-DERIVED POLIOVIRUS TYPE 2 (cVDPV2) OUTBREAK R
![Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance](https://www.thelancet.com/cms/attachment/a9a85333-4c32-43b8-8596-f3e0557254f4/gr1_lrg.jpg)